Literature DB >> 2864056

Celiprolol: pharmacokinetics and duration of pharmacodynamic activity.

F S Caruso, H D Doshan, P H Hernandez, R Costello, W Applin, E S Neiss.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2864056

Source DB:  PubMed          Journal:  Br J Clin Pract Suppl        ISSN: 0262-8767


× No keyword cloud information.
  20 in total

1.  Hemodynamic effects of celiprolol at rest and during exercise; a comparison with enalapril.

Authors:  S Ghiringhelli; E Cozzi; D Tsialtas
Journal:  Cardiovasc Drugs Ther       Date:  1988-07       Impact factor: 3.727

2.  Comparison of the antihypertensive effects of celiprolol and acebutolol.

Authors:  D Terziivanov; V Vlahov; N Belovezhdov; Z Gerova
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

Review 3.  Predictive Value of Microdose Pharmacokinetics.

Authors:  Merel van Nuland; Hilde Rosing; Alwin D R Huitema; Jos H Beijnen
Journal:  Clin Pharmacokinet       Date:  2019-10       Impact factor: 6.447

Review 4.  Evaluation of celiprolol, a new cardioselective beta 1-adrenergic blocker with vasodilating properties, in the treatment of mild to moderate hypertension in the elderly.

Authors:  K D Lamon
Journal:  Cardiovasc Drugs Ther       Date:  1991-01       Impact factor: 3.727

5.  Transport of celiprolol across human intestinal epithelial (Caco-2) cells: mediation of secretion by multiple transporters including P-glycoprotein.

Authors:  J Karlsson; S M Kuo; J Ziemniak; P Artursson
Journal:  Br J Pharmacol       Date:  1993-11       Impact factor: 8.739

Review 6.  Pharmacological profile of beta-adrenoceptor blockers with vasodilating properties, especially carvedilol--rationale for clinical use.

Authors:  G Sponer; W Bartsch; K Strein
Journal:  Clin Investig       Date:  1992

7.  Celiprolol double-peak occurrence and gastric motility: nonlinear mixed effects modeling of bioavailability data obtained in dogs.

Authors:  E Lipka; I D Lee; P Langguth; H Spahn-Langguth; E Mutschler; G L Amidon
Journal:  J Pharmacokinet Biopharm       Date:  1995-06

8.  The contribution of intestinal secretion to the dose-dependent absorption of celiprolol.

Authors:  S M Kuo; B R Whitby; P Artursson; J A Ziemniak
Journal:  Pharm Res       Date:  1994-05       Impact factor: 4.200

Review 9.  Celiprolol. An evaluation of its pharmacological properties and clinical efficacy in the management of hypertension and angina pectoris.

Authors:  C J Dunn; C M Spencer
Journal:  Drugs Aging       Date:  1995-11       Impact factor: 3.923

10.  Comparative enantioselective pharmacokinetic studies of celiprolol in healthy volunteers and patients with impaired renal function.

Authors:  C Hartmann; M Frölich; D Krauss; H Spahn-Langguth; H Knauf; E Mutschler
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.